Is Biohaven profitable?

Biohaven is not currently profitable: it reported a net loss of $647.7M over the trailing twelve months.

What is Biohaven's earnings per share?

Biohaven's diluted EPS over the trailing twelve months is $-5.58.

Where does Biohaven's income statement data come from?

Every line is extracted from Biohaven's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Biohaven BHVN Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Research and development	$103.83M-14.9%	$121.95M-13.6%	$141.17M-23.4%	$184.37M-1.7%	$187.58M+12.0%
General and administrative	$26.6M+28.0%	$20.79M-26.3%	$28.21M+3.2%	$27.33M-19.6%	$33.98M+51.3%
Total costs & expenses	$130.43M-8.6%	$142.73M-15.7%	$169.38M-20.0%	$211.7M-4.5%	$221.56M+16.7%
Operating income	-$130.43M+8.6%	-$142.73M+15.7%	-$169.38M+20.0%	-$211.7M+4.5%	-$221.56M-16.7%
Other income (expense), net	$168K—	——	-$3.84M-128%	$13.82M+2,702%	$493K-84.3%
Income before income taxes	-$130.26M+10.3%	-$145.2M+16.2%	-$173.22M+12.5%	-$197.89M+10.5%	-$221.07M-18.3%
Income tax expense	$272K-22.5%	$351K+58.8%	$221K-15.3%	$261K-57.1%	$609K+1,169%
Net income	-$130.53M+10.3%	-$145.56M+16.1%	-$173.44M+12.5%	-$198.15M+10.6%	-$221.68M-18.6%
Diluted earnings per share	-$0.88+21.4%	-$1.12+31.7%	-$1.64+15.5%	-$1.94+10.6%	-$2.17-21.9%
Basic earnings per share	-$0.88+21.4%	-$1.12+31.7%	-$1.64+15.5%	-$1.94+10.6%	-$2.17-21.9%
Weighted-average shares, diluted	147.6M+37.2%	107.6M+1.7%	105.8M+3.4%	102.4M+0.4%	101.9M+11.7%
Weighted-average shares, basic	147.6M+37.2%	107.6M+1.7%	105.8M+3.4%	102.4M+0.4%	101.9M+11.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	-$130.58M—	——	-$173.4M+12.5%	-$198.22M+10.6%	-$221.68M—
Other comprehensive income (loss)	-$46K—	——	$39K+151%	-$76K-1,167%	-$6K—
EBIT	-$130.43M+8.6%	-$142.73M+15.7%	-$169.38M+20.0%	-$211.7M+4.5%	-$221.56M-16.7%
EBITDA	-$128.06M+8.6%	-$140.16M+15.7%	-$166.26M+20.7%	-$209.72M+4.4%	-$219.32M-17.0%
EBITDA	-$128.06M+8.6%	-$140.16M+15.7%	-$166.26M+20.7%	-$209.72M+4.4%	-$219.32M-17.0%
EBIT	-$130.43M+8.6%	-$142.73M+15.7%	-$169.38M+20.0%	-$211.7M+4.5%	-$221.56M-16.7%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Is Biohaven profitable?: Biohaven is not currently profitable: it reported a net loss of $647.7M over the trailing twelve months.
What is Biohaven's earnings per share?: Biohaven's diluted EPS over the trailing twelve months is $-5.58.
Where does Biohaven's income statement data come from?: Every line is extracted from Biohaven's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.